Doctor Life

Optimized Singles

Akkermansia PostBiotic

Akkermansia muciniphila AH39

150,00 zł

Tax included. Shipping calculated at checkout.

Build your routine

Four categories. Find the support that fits your needs.

  • A pasteurized postbiotic form with no need to maintain live cultures
  • The specific AH39 strain, studied in a human clinical trial
  • A contemporary approach focused on the microbiome and metabolism

Overview

A postbiotic approach to the microbiome. Akkermansia PostBiotic uses pasteurized Akkermansia muciniphila AH39, a nonliving form of this microorganism. Unlike a probiotic, its value does not depend on the bacteria retaining the ability to multiply after consumption.

At the heart of the formula / Akkermansia PostBiotic

Thoughtful support. Clear purpose.

  1. 01A pasteurized postbiotic form with no need to maintain live cultures
  2. 02The specific AH39 strain, studied in a human clinical trial
  3. 03A contemporary approach focused on the microbiome and metabolism
  4. 04A clear, single-ingredient formula
  5. 05Cell count declared in TFU, appropriate for the pasteurized form
  6. 06Store at room temperature
Doctor Life / 01

Akkermansia PostBiotic

Made for your daily routine.

The formula uses the specific strain AH39. Strain identity matters: evidence for one microorganism cannot automatically be applied to another. The ingredient supplier cites a randomized, double-blind human study of postbiotic Akkermansia in adults with overweight or obesity, examining body composition, appetite, and metabolic measures.

Because the bacteria are pasteurized, the product does not depend on maintaining live cultures. This supports storage at room temperature. The supplier reports cell quantity in total fluorescent units (TFU) using its specified method, rather than the colony-forming units (CFU) used for viable cultures.

Akkermansia muciniphila naturally inhabits the mucus layer of the large intestine. Researchers study its relationship with the gut barrier and metabolism. Human trials of pasteurized preparations have examined insulin sensitivity, cholesterol, body composition, and weight maintenance. Findings depend on the strain and preparation studied.

Doctor Life / 02

Akkermansia PostBiotic

Why are researchers interested in Akkermansia muciniphila?

Akkermansia muciniphila lives in the intestinal mucus layer and interacts closely with mucin and the gut lining. Studies have linked its presence with several metabolic measures, prompting research into specific preparations as microbiome ingredients. Human evidence must be evaluated by strain, preparation, and serving rather than by species name alone.

Doctor Life / 03

Akkermansia PostBiotic

What research informs Akkermansia PostBiotic?

Human studies have explored pasteurized Akkermansia in several settings. A 2025 trial of postbiotic Akkermansia in yogurt, cited by the AH39 ingredient supplier, reported changes in waist circumference, body fat percentage, and appetite scores. A 2019 exploratory trial examined insulin sensitivity and cholesterol, while a 2026 trial studied weight maintenance after weight loss using the MucT strain. These are different study preparations; their results do not establish the effects of this finished capsule.

Ingredients / Doctor Life

Every ingredient. Clearly explained.

Each ingredient, its form and quantity — in one place.

Ingredient amounts for the servings shown in the table.
Ingredient1 capsule2 capsules
Akkermansia muciniphila AH39300 mg / 15 billion TFU*600 mg / 30 billion TFU*

*NRV: Nutrient Reference Value

Full ingredient list

Pasteurized Akkermansia muciniphila, capsule shell (pullulan).

How to use

Part of your daily rhythm.

01

How to use

Daily serving for adults: take 1–2 capsules at least 30 minutes before food. May be combined with the Ozem-Slim formula.

02

Important information

Do not exceed the recommended daily serving. Food supplements should not replace a varied diet. A balanced diet and a healthy lifestyle are recommended. Not suitable for children or women who are pregnant or breastfeeding. Store in a dry place at room temperature, up to 25°C, out of reach of young children.

Science & sources

Understand the formula.

Akkermansia muciniphila has progressed from a focus of microbiome research to an ingredient evaluated in randomized human trials. The study identified by the AH39 manufacturer is particularly relevant to this product, alongside research on pasteurized Akkermansia muciniphila in insulin sensitivity and weight-loss maintenance.

These publications concern the studied ingredients or formulas. They do not all evaluate the finished Doctor Life product, and research results do not guarantee individual outcomes.

01Comparing the effects of yogurt containing Akkermansia muciniphilia postbiotic with yogurt containing Lactobacillus rhamnosus postbiotic on body composition, biochemical indices, appetite, and depression scores in overweight or obese adults: A randomized, double-blind, controlled clinical trial

Erfaneh Aalipanah, Moein Askarpour, Mohammad Hadi Eskandari, Morteza Zare, Mandana Famouri, Alireza Bedeltavana, Mohammad Ali Mohsenpour, Zahra Sohrabi

Clinical Nutrition ESPEN (2025), 68, 438-446. DOI: 10.1016/j.clnesp.2025.05.045; PMID: 40451504.

In an eight-week randomized, double-blind trial, 66 adults with overweight or obesity received yogurt enriched with an Akkermansia muciniphila postbiotic, yogurt with a Lacticaseibacillus rhamnosus postbiotic, or control yogurt. Compared with the control group, the Akkermansia group showed significant reductions in waist circumference, waist-to-height ratio, body fat percentage, AST, and appetite scores. The AH39 ingredient manufacturer identifies this publication as a clinical study of its strain.

Read publication ↗
02Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study

Clara Depommier et al.

Nature Medicine (2019), 25(7), 1096-1103. DOI: 10.1038/s41591-019-0495-2; PMID: 31263284.

In a three-month randomized, double-blind, placebo-controlled study, adults with overweight or obesity and insulin resistance took live or pasteurized Akkermansia muciniphila. Compared with placebo, the pasteurized form improved insulin sensitivity by 28.62%, reduced insulin levels by 34.08%, and lowered total cholesterol by 8.68%. The findings showed that pasteurization did not eliminate biological activity and contributed to research on Akkermansia as a postbiotic.

Read publication ↗
03Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity: a controlled randomized trial

Sarah Mount, Emanuel E. Canfora, Johan W. Jocken et al.

Nature Medicine (2026), 32(6), 2107-2116. DOI: 10.1038/s41591-026-04394-7; PMID: 42120725.

In a randomized trial, 90 adults with overweight or obesity who had previously lost at least 8% of their body weight received pasteurized A. muciniphila MucT or a placebo for 24 weeks. The Akkermansia group regained an average of 1.2 kg, compared with 3.2 kg in the placebo group, and total weight loss from the start of the program was 3.1 kg greater. The study contributes to research on pasteurized Akkermansia for weight-loss maintenance.

Read publication ↗

FAQ / Akkermansia PostBiotic

Good questions. Clear answers.

Talk to us ↗
Can a preparation have an effect if its bacteria are no longer alive?

Yes. Postbiotics are preparations of inanimate microorganisms or their components with a demonstrated health benefit; they do not need to multiply in the gut. Human trials have studied certain pasteurized Akkermansia preparations, including a 2019 trial examining insulin sensitivity and other metabolic measures. Effects depend on the specific preparation.

How does Akkermansia PostBiotic differ from a probiotic?

Probiotics contain live microorganisms. This product contains pasteurized, nonliving Akkermansia muciniphila AH39, so it does not require a viable culture to be maintained through storage. Its cell quantity is therefore reported using a method appropriate to the pasteurized preparation.

Why does the label use TFU instead of CFU?

CFU means colony-forming units and measures microorganisms able to form colonies. Pasteurized Akkermansia is not expected to grow in that way. The supplier instead uses total fluorescent units (TFU), measured by its specified method, to quantify cells in the preparation.

What human research does the AH39 supplier cite?

The ingredient supplier cites an eight-week randomized, double-blind study published in Clinical Nutrition ESPEN in 2025. It tested yogurt containing postbiotic Akkermansia in adults with overweight or obesity and reported improvements in several measures compared with the control, including waist circumference and body fat percentage. The study used a yogurt preparation, so its findings should not be presented as a clinical trial of this finished capsule.

Is pasteurized Akkermansia less active than live Akkermansia?

Not necessarily. Pasteurization makes the microorganisms nonliving but does not automatically remove all biological activity. A 2019 Nature Medicine study reported changes in insulin sensitivity, insulin levels, and total cholesterol with a specific pasteurized preparation. This does not mean all pasteurized strains or products have the same effects.

Does the product need refrigeration?

No. Store in a dry place at room temperature, up to 25°C. The pasteurized preparation does not depend on keeping bacteria alive during transport and storage.

Is Akkermansia simply a weight-loss supplement?

Research covers a wider range of microbiome and metabolic questions, including body composition, appetite, insulin sensitivity, blood lipids, and weight maintenance. This product is not a substitute for a balanced diet, physical activity, or medical treatment, and weight-loss results should not be assumed.